Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 52.94% |
| 2 | Technology | 8.23% |
| 3 | Healthcare | 7.53% |
| 4 | Financials | 7.5% |
| 5 | Industrials | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATCO
3426
CALL
DELISTED
Atlas Corp.
ATCO
| $2.25M | ﹤0.01% |
146,600
-79,400
| -35% | -$1.2M |
|
3427
Lexicon Pharmaceuticals
LXRX
$1.02B
| $2.25M | ﹤0.01% |
1,176,567
+270,656
| +30% | +$576K |
|
3428
CALL
Globus Medical
GMED
$11.1B
| $2.24M | ﹤0.01% |
30,200
+200
| +0.7% | +$13.6K |
|
3429
Harrow
HROW
$1.4B
| $2.24M | ﹤0.01% |
151,503
+51,689
| +52% | +$618K |
|
|
CHUY
3430
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.24M | ﹤0.01% |
79,011
+59,319
| +301% | +$1.72M |
|
|
CERO
3431
DELISTED
CERo Therapeutics
CERO
| $2.23M | ﹤0.01% |
109
-2
| -2% | -$40.8K |
|
3432
PUT
Match Group
MTCH
$9.54B
| $2.23M | ﹤0.01% |
53,700
-363,400
| -87% | -$16.4M |
|
3433
Northrim BanCorp
NRIM
$571M
| $2.23M | ﹤0.01% |
163,264
-69,904
| -30% | -$882K |
|
|
MASI
3434
CALL
DELISTED
Masimo
MASI
| $2.22M | ﹤0.01% |
15,000
+13,000
| +650% | +$1.79M |
|
|
EXK
3435
Endeavour Silver
EXK
$3.19B
| $2.21M | ﹤0.01% |
683,370
+600,871
| +728% | +$2.02M |
|
|
DCT
3436
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $2.2M | ﹤0.01% |
182,925
-159,580
| -47% | -$1.83M |
|
3437
Kimco Realty
KIM
$16B
| $2.2M | ﹤0.01% |
+104,032
| New | +$2.19M |
|
3438
Sensient Technologies
SXT
$5.75B
| $2.2M | ﹤0.01% |
30,188
+15,137
| +101% | +$1.08M |
|
3439
CALL
Intellia Therapeutics
NTLA
$1.8B
| $2.19M | ﹤0.01% |
+62,700
| New | +$2.98M |
|
3440
American Vanguard Corp
AVD
$64.6M
| $2.19M | ﹤0.01% |
+100,726
| New | +$2.24M |
|
|
ACLX
3441
DELISTED
Arcellx
ACLX
| $2.18M | ﹤0.01% |
70,277
+49,039
| +231% | +$1.12M |
|
3442
Alto Ingredients
ALTO
$316M
| $2.17M | ﹤0.01% |
754,399
-169,997
| -18% | -$604K |
|
3443
Korn Ferry
KFY
$4.43B
| $2.17M | ﹤0.01% |
42,887
-43,804
| -51% | -$2.33M |
|
3444
Kulicke & Soffa
KLIC
$4.24B
| $2.17M | ﹤0.01% |
48,995
-10,430
| -18% | -$458K |
|
|
APEN
3445
CALL
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.17M | ﹤0.01% |
+217,600
| New | +$1.62M |
|
3446
Coinbase
COIN
$47.1B
| $2.17M | ﹤0.01% |
+61,269
| New | +$3.23M |
|
3447
Business First Bancshares
BFST
$1.02B
| $2.17M | ﹤0.01% |
+97,845
| New | +$2.24M |
|
|
RPC
3448
Ridgepost Capital
RPC
$955M
| $2.16M | ﹤0.01% |
202,763
+15,797
| +8% | +$164K |
|
3449
CALL
Idexx Laboratories
IDXX
$43.7B
| $2.16M | ﹤0.01% |
5,300
-3,700
| -41% | -$1.44M |
|
3450
WhiteHorse Finance
WHF
$152M
| $2.16M | ﹤0.01% |
165,410
+151,457
| +1,085% | +$1.91M |
|
Similar funds
Israel Englander's Q4 2022 Portfolio in Review
As of Q4 2022, Israel Englander held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Israel Englander's Q4 2022 filing shows 848 new, 2,516 increased, 2,491 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, down from 55% a quarter earlier, followed by Technology and Healthcare.
- Israel Englander's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Israel Englander added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Israel Englander's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Israel Englander fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Israel Englander's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Israel Englander opened 848 new positions and closed 1,332 in Q4 2022.
- Israel Englander's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.